Диссертация (1140954), страница 14
Текст из файла (страница 14)
Mayer, K.Lahl, C. Loddenkemper, M.W. Teng, S.F. Ngiow et al. // Cancer Res. – 2010. –V. 70. – P. 7788–7799.97.Koch M.A. The transcription factor T-bet controls regulatory T cell homeostasisand function during type 1 inflammation / M.A.
Koch, Gs. Tucker-Heard, N.R.Perdue, J.R. Killebrew, K.B. Urdahl, D.J. Campbell // Nat Immunol. – 2009. – V.10. – P. 595–602.98.Kodama J. Association of CXCR4 and CCR7 chemokine receptor expression andlymph node metastasis in human cervical cancer / J. Kodama, Hasengaowa, T.92Kusumoto, N. Seki, T. Matsuo et al. // Ann.
Oncol. – 2007. – V. 18(1). – P. 70–76.99.Koishi K. Persistent CXCR4 expression after preoperative chemoradiotherapypredicts early recurrence and poor prognosis in esophageal cancer / K. Koishi, R.Yoshikawa, T. Tsujimura, T. Hashimoto-Tamaoki, S. Kojima et al. //World JGastroenterol. – 2006. – V.
12(47). – P. 7585–7590.100. Kortylewski M. In vivo delivery of siRNA to immune cells by conjugation to aTLR9 agonist enhances antitumor immune responses / M. Kortylewski et al. //Nat Biotechnol. – 2009. – V. 27. – P. 925–932.101. Krieg A.M. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer / A.M.Krieg // Oncogene. – 2008. – V. 27.
– P. 161–167.102. Kryczek I. CXCL12 and vascular endothelial growth factor synergistically induceneoangiogenesis in human ovarian cancers / I. Kryczek, A. Lange, P. Mottram, X.Alvarez,P. Cheng et al. // Cancer Res. – 2005.– V. 65(2). – P. 465–472.103. Kuraishy A. Tumor promotion via injury- and death-induced inflammation / A.Kuraishy, M. Karin, S.I. Grivennikov // Immunity. – 2011.
– V. 35. – P. 467–477.104. Lan T. Stabilized immune modulatory RNA compounds as agonists of Toll-likereceptors 7 and 8 / T. Lan et al. // Proc Natl Acad Sci U S A. – 2007. – V. 104. –P. 13750–13755.105. Lau T.S. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromalinteractions in human ovarian cancer by inducing CXCL11 in fibroblasts / T.S.Lau, T.K.H. Chung, T.H.
Cheung, L.K.Y. Chan, L.W.H. Cheung, S.F. Yim, et al.// J Pathol. – 2014. – V. 232. – P. 43–56.106. Lee J. Activation of innate immunity is required for efficient nuclearreprogramming / J. Lee et al. // Cell. – 2012. – V. 151. – P. 547–558.107. Letsch A. Functional CCR9 expression is associated with small intestinalmetastasis / A.
Letsch, U. Keilholz, D. Schadendorf, G. Assfalg, A.M. Asemissenet al. // J. Invest. Dermatol. – 2004. – V. 122(3). – P. 685–690.93108. Li L. Dendritic cells generated from acute myeloid leukemia (AML) blastsmaintain the expression of immunogenic leukemia associated antigens / L. Li, P.Reinhardt, A. Schmitt, T.F. Barth, J.
Greiner et al. // Cancer ImmunolImmunother – 2005. – V. 54(7). – P. 685–693.109. Li P. Chemokine receptor 7 promotes cell migration and adhesion in metastaticsquamous cell carcinoma of the head and neck by activating integrin alphavbeta3/ P. Li, F. Liu, L. Sun, Z. Zhao, X. Ding et al. // Int. J. Mol. Med. – 2011. – V.27(5). – P. 679–687.110. Li X. Efficient Treg depletion induces T-cell infiltration and rejection of largetumors / X. Li, E. Kostareli, J. Suffner, N. Garbi, G.J.
Hämmerling // Eur JImmunol. – 2010. – V. 40. – P. 3325–3335.111. Li Y. Gut microbiota accelerate tumor growth via c-jun and STAT3phosphorylation in APCMin/+ mice / Y. Li et al. // Carcinogenesis. – 2012. – V.33. – P. 1231–1238.112. Liang Z. Inhibition of breast cancer metastasis by selective synthetic polypeptideagainst CXCR4 / Z. Liang, T.
Wu, H. Lou, X. Yu, R.S. Taichman et al. // CancerRes. – 2004. – V. 64(12). – P. 4302–4308.113. Lin H. Loss of immunity-supported senescence enhances susceptibility tohepatocellular carcinogenesis and progression in Toll-like receptor 2-deficientmice / H. Lin et al. // Hepatology. – 2013. – V. 57. – P. 171–182.114. Liu F.Y. NF-kappaB participates in chemokine receptor 7-mediated cell survivalin metastatic squamous cell carcinoma of the head and neck / F.Y. Liu, Z.J.
Zhao,P. Li, X. Ding, N. Guo et al. // Oncol. Rep. – 2011. – V. 25(2). – P. 383–391.115. Liu Y. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptorsin predicting breast cancer metastasis and prognosis / Y. Liu, R. Ji, J. Li, Q. Gu,X. Zhao et al. // J. Exp.
Clin. Cancer Res. – 2010. – V. 29. – P. 16.94116. Li Y.M. Upregulation of CXCR4 is essential for HER2-mediated tumormetastasis / Y.M. Li, Y. Pan, Y. Wei, X. Cheng, B.P. Zhou et al. // Cancer Cell. –2004. – V. 6(5). – P. 459–469.117. Liu X. The synergistic repressive effect of NF-κB and JNK inhibitor on theclonogenic capacity of Jurkat leukemia cells / X. Liu, J. Zhang, J. Li, A.
Volk, P.Breslin et al. // PLoS ONE. – 2014. – V. 9(12). – P. e115490118. Lohr J.G. Discovery and prioritization of somatic mutations in diffuse large Bcell lymphoma (DLBCL) by whole-exome sequencing / J.G. Lohr et al. // ProcNatl Acad Sci U S A. – 2012. – V. 109. – P. 3879–3884.119. Lofgren J.L. Lack of commensal flora in Helicobacter pylori-infected INS-GASmice reduces gastritis and delays intraepithelial neoplasia / J.L.
Lofgren et al. //Gastroenterology. – 2011. – V. 140. – P. 210–220.120. Lopez-Giral S. Chemokine receptors that mediate B cell homing to secondarylymphoid tissues are highly expressed in B cell chronic lymphocytic leukemiaand non-Hodgkin lymphomas with widespread nodular dissemination / S. LopezGiral, N.E.
Quintana, M. Cabrerizo, M. Alfonso-Perez, M. Sala-Valdes et al. // J.Leukoc. Biol. – 2004. – V. 76(2). – P. 462–471.121. Lotze M.T. The grateful dead: damage-associated molecular pattern moleculesand reduction/oxidation regulate immunity / M.T. Lotze et al. // Immunol Rev. –2007. – V. 220. – P. 60–81122. Lowe E.L. Toll-like receptor 2 signaling protects mice from tumor developmentin a mouse model of colitis-induced cancer / E.L.
Lowe et al. // PloS one. – 2010.– V. 5. – P. e13027.123. Luan J. Mechanism and biological significance of constitutive expression ofMGSA/GRO chemokines in malignant melanoma tumor progression / J. Luan, R.Shattuck-Brandt, H. Haghnegahdar, J.D. Owen, R. Strieter et al. // J. Leukoc.Biol. – 1997. – V. 62(5). – P. 588–597.95124. Luker K.E. Functions of CXCL12 and CXCR4 in breast cancer / K.E.
Luker,G.D. Luker // Cancer Lett. – 2006. – V. 238(1). – P. 30-41125. Luster A.D. The IP-10 chemokine binds to a specific cell surface heparan sulfatesite shared with platelet factor 4 and inhibits endothelial cell proliferation / A.D.Luster, S.M. Greenberg, P. Leder // J Exp Med. – 1995. – V. 182. – P. 219–31.126. Maeda S. IKKbeta couples hepatocyte death to cytokine-driven compensatoryproliferation that promotes chemical hepatocarcinogenesis / S.
Maeda, H.Kamata, J.L. Luo, H. Leffert, M. Karin // Cell. – 2005. – V. 121. – P. 977–990.127. Marchesi F. Increased survival, proliferation, and migration in metastatic humanpancreatic tumor cells expressing functional CXCR4 / F. Marchesi, P. Monti,B.E. Leone, A. Zerbi, A. Vecchi et al. // Cancer Res. – 2004. – V.
64(22). – P.8420–8427.128. Mashino K. Expression of chemokine receptor CCR7 is associated with lymphnode metastasis of gastric carcinoma / K. Mashino, N. Sadanaga, H. Yamaguchi,F. Tanaka, M. Ohta et al. // Cancer Res. – 2002. – V. 62(10). – P. 2937–2941.129. Mattern J. Association of vascular endothelial growth factor expression withintratumoral microvessel density and tumour cell proliferation in humanepidermoid lung carcinoma / J. Mattern, R. Koomagi, M.
Volm // Br. J. Cancer. –1996. – V. 73(7). – P. 931–934.130. Marechal R. High expression of CXCR4 may predict poor survival in resectedpancreatic adenocarcinoma / R. Marechal, P. Demetter, N. Nagy, A. Berton, C.Decaestecker et al. // Br. J. Cancer. – 2009. – V. 100(9). – P. 1444–1451.131. Mburu Y.K. Chemokine receptor 7 (CCR7) gene expression is regulated by NFkappaB and activator protein 1 (AP1) in metastatic squamous cell carcinoma ofhead and neck (SCCHN) / Y.K. Mburu, A.M. Egloff, W.H. Walker, L. Wang,R.R. Seethala et al.
// J. Biol. Chem. – 2012. – V. 287(5). – P. 3581–3590.132. Mittal D. TLR4-mediated skin carcinogenesis is dependent on immune andradioresistant cells / D. Mittal et al. // EMBO J. – 2010. – V. 29. – P. 2242–2252.96133. Medzhitov R. Origin and physiological roles of inflammation / R. Medzhitov //Nature. – 2008. – V. 454. – P. 428–435.134. Merrell M. Toll-like receptor 9 agonists promote cellular invasion by increasingmatrix metalloproteinase activity / M. Merrell et al. // Molecular cancer research:MCR.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
